The new LDL-C target <55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data
28 August 2020 (08:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Attikon University Hospital, Athens (Greece)
217 More presentations in this session
Assistant Professor C. Wu (Beijing, CN)
Access the full session
The Event
ESC Congress 2020
28 August 2020
08:00 CET
You may be interested in
Congress Presentation
Congress Session
24 June 2023
Congress Presentation
Congress Presentation
